US 7879838
Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity
granted A61PA61P1/04A61P17/00
Quick answer
US patent 7879838 (Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61P, A61P1/04, A61P17/00, A61P17/06, A61P19/00